Two drug candidates can target biological pathways involved in the destruction of brain cells in Parkinson's disease, scientists have reported. The studies suggest that it is possible to design highly effective and highly selective (targeted) drug candidates that can protect the function of mitochondria, which provide the cell with energy, ultimately preventing brain cell death.